The German Breast Group conducts research into breast cancer, developing and implementing its own study concepts.
With the help of additional scientific research projects, we strive to gain further insights into this disease.
We are delighted to inform you that an overview of data on CDK4/6 inhibitors in the treatment of breast cancer has been published in Breast.
We are happy to present our work at the San Antonio Breast Cancer Symposium, December 7-10 2021
The survival analysis of the randomized phase III GeparOcto trial has been published in European Journal of Cancer
An analysis evaluating RAD51 test and its association with HRD and clinical outcome in primary TNBC from GeparSixto trial has been published in Annals of Oncology.
We are delighted to inform you that our results on the GAIN-2 trial has been published in European Journal of Cancer
Every month, we present an interesting paper.
We are pleased to inform you that long-term outcomes from GeparNuevo trial have been published in Annals of Oncology.